{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T15:54:28Z","timestamp":1789401268111,"version":"build-2803163510"},"reference-count":10,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T00:00:00Z","timestamp":1660262400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontierspartnerships.org"],"crossmark-restriction":true},"short-container-title":["Transpl Int"],"DOI":"10.3389\/ti.2022.10681","type":"journal-article","created":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T04:11:41Z","timestamp":1660277501000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":12,"title":["Abatacept Rescue Therapy in Kidney Transplant Recipients: A Case Series of Five Patients"],"prefix":"10.3389","volume":"35","author":[{"given":"Charlotte","family":"Uro-Coste","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alba","family":"Atenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Elisabeth","family":"Heng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul-Olivier","family":"Rouzaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril","family":"Garrouste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1007\/s40265-017-0775-4","article-title":"Abatacept: A Review in Rheumatoid Arthritis","volume":"77","author":"Blair","year":"2017","journal-title":"Drugs"},{"key":"B2","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1056\/NEJMoa1506027","article-title":"Belatacept and Long-Term Outcomes in Kidney Transplantation","volume":"374","author":"Vincenti","year":"2016","journal-title":"N Engl J Med"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1097\/TP.0000000000002192","article-title":"Conversion to Belatacept in Maintenance Kidney Transplant Patients: A Retrospective Multicenter European Study","volume":"102","author":"Darres","year":"2018","journal-title":"Transplantation"},{"key":"B4","doi-asserted-by":"publisher","first-page":"3252","DOI":"10.1681\/ASN.2021050628","article-title":"Conversion from Calcineurin Inhibitor to Belatacept-Based Maintenance Immunosuppression in Renal Transplant Recipients: a Randomized Phase 3b Trial","volume":"32","author":"Budde","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"B5","doi-asserted-by":"publisher","first-page":"2342","DOI":"10.1111\/ajt.15319","article-title":"Abatacept as rescue Immunosuppression after Calcineurin Inhibitor Treatment Failure in Renal Transplantation","volume":"19","author":"Badell","year":"2019","journal-title":"Am J Transpl"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1007\/s10067-017-3788-1","article-title":"Body Mass index and Clinical Response to Intravenous or Subcutaneous Abatacept in Patients with Rheumatoid Arthritis","volume":"36","author":"D\u2019Agostino","year":"2017","journal-title":"Clin Rheumatol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"430","DOI":"10.2215\/CJN.05840710","article-title":"Switching from Calcineurin Inhibitor-Based Regimens to a Belatacept-Based Regimen in Renal Transplant Recipients: a Randomized Phase II Study","volume":"6","author":"Rostaing","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S0041-1345(22)00107-5","DOI":"10.1016\/j.transproceed.2021.12.046","article-title":"Transplant Recipient Experience with Belatacept Therapy","volume":"2022","author":"Little","year":"2022","journal-title":"Transpl Proc"},{"key":"B9","doi-asserted-by":"publisher","first-page":"1691","DOI":"10.1111\/ajt.17005","article-title":"CD86 Occupancy in Belatacept-Treated Kidney Transplant Patients Is Not Associated with Clinical and Infectious Outcomes","volume":"22","author":"De Nattes","year":"2022","journal-title":"Am J Transpl"},{"key":"B10","doi-asserted-by":"publisher","first-page":"2448","DOI":"10.1111\/ajt.16430","article-title":"Increased Incidence and Unusual Presentations of CMV Disease in Kidney Transplant Recipients after Conversion to Belatacept","volume":"21","author":"Chavarot","year":"2021","journal-title":"Am J Transpl"}],"container-title":["Transplant International"],"original-title":[],"link":[{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2022.10681\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,12]],"date-time":"2022-08-12T04:11:43Z","timestamp":1660277503000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontierspartnerships.org\/articles\/10.3389\/ti.2022.10681\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,12]]},"references-count":10,"alternative-id":["10.3389\/ti.2022.10681"],"URL":"https:\/\/doi.org\/10.3389\/ti.2022.10681","relation":{},"ISSN":["1432-2277"],"issn-type":[{"value":"1432-2277","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,12]]},"article-number":"10681"}}